MCMVX
Price
$24.67
Change
-$0.00 (-0.00%)
Updated
Sep 4 closing price
Net Assets
48.29M
MVCAX
Price
$34.95
Change
-$0.14 (-0.40%)
Updated
Sep 4 closing price
Net Assets
17.3B
Interact to see
Advertisement

MCMVX vs MVCAX

MCMVX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
MCMVX vs. MVCAX commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCMVX is a Hold and MVCAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.3B vs. MCMVX (48.3M). MVCAX pays higher dividends than MCMVX: MVCAX (1.08) vs MCMVX (0.99). MCMVX was incepted earlier than MVCAX: MCMVX (13 years) vs MVCAX (25 years). MCMVX (1.60) is less costly to investors than MVCAX (0.98). MCMVX is a more actively managed with annual turnover of: 37.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than MCMVX: MVCAX (1000) vs MCMVX (5000). MCMVX annual gain was more profitable for investors over the last year : 18.87 vs. MVCAX (9.32). MCMVX return over 5 years is better than : 32.01 vs. MVCAX (16.01).
MCMVXMVCAXMCMVX / MVCAX
Total Expense Ratio0.860.9789%
Annual Report Gross Expense Ratio1.600.98163%
Fund Existence13 years25 years-
Gain YTD20.04916.229124%
Front LoadN/A6%-
Min. Initial Investment50001000500%
Min. Initial Investment IRAN/AN/A-
Net Assets48.3M17.3B0%
Annual Yield % from dividends0.991.0892%
Returns for 1 year18.879.32202%
Returns for 3 years46.1026.72173%
Returns for 5 years32.0116.01200%
Returns for 10 years130.8183.64156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECZX60.310.32
+0.53%
AMG GW&K International Small Cap Z
MLPFX11.23N/A
N/A
Invesco SteelPath MLP Select 40 A
PFISX13.49-0.01
-0.07%
Principal International Small Company R6
JAMCX34.56-0.13
-0.37%
JPMorgan Mid Cap Value A
BIVRX18.63-0.31
-1.64%
Invenomic Investor